CI First Asset Health Care Giants Covered Call ETF (CAD Hedged)

Fund Overview

The ETF's investment objectives are to provide holders, through an actively managed portfolio, with (i) regular cash distributions, (ii) the opportunity for capital appreciation by investing on an equal weight basis in a portfolio of securities of the 20 health care companies (as determined by the Manager in its discretion) with the largest market capitalization listed on a North American stock exchange, and (iii) lower overall volatility of returns on the portfolio than would be experienced by owning a portfolio of securities of such issuers directly, by employing a covered call option writing program. It is intended that at all times at least 90% of the foreign currency denominated assets held by the Fund attributable to the Units will be hedged back to the Canadian dollar.

Investor suitability
For those who:

  • want exposure to North American listed Health Care companies on a CADhedged basis
  • want the potential for high income generation
  • want to receive regular cash flows (if any)
  • Can tolerate medium risk.


FHI -1.11%4.95%17.02%-0.25%11.32%3.51%8.08%
As at: 30 Sep 2020 - Benchmark: S&P 500 Health Care Index


Historical NAVs

Sector Breakdown

As at September 30, 2020

The indicated rates of return are the historical annual compounded total returns, including changes in unit value and do not take into account sales, redemption or optional charges or income taxes payable by a security holder that would have reduced returns.

S&P 500 Health Care Index is a market capitalization weighted index. The constituents of the Index are a subset of the constituents of the S&P 500 Index that have been classified as part of the health care sector according to the Global Industry Classification Standard.

Key Facts

Fund Characteristics

Gross Option Premium*6.55%
Current Dividend Yield12.03%
Price/Earnings Ratio21.46
Price/Book Ratio3.64
As at 30 Sep, 2020
* Gross Option Premiums represent those received on 18 Sep, 2020
1 The Current Dividend Yield represents the gross yield on the ETF`s underlying portfolio of securities. It is not the yield or the distribution investors will receive by virtue of an investment in the ETF.

Fund Statistics

P/S Ratio (TTM) (Long)1.58
P/C Ratio (TTM) (Long)12.49
ROA % (TTM) (Long)6.86
ROE % (TTM) (Long)25.79
As at 30 Sep, 2020

Number of securities: 40

Asset Allocation

Security Type%
Foreign Stock100.00%


NameSecurity TypeISINTicker %
ANTHEM INC Foreign StockUS0367521038 ANTM US 5.75
DANAHER CORP Foreign StockUS2358511028 DHR US 5.48
HUMANA INC Foreign StockUS4448591028 HUM US 5.39
CIGNA CORP Foreign StockUS1255231003 CI US 5.34
UNITEDHEALTH GROUP INC Foreign StockUS91324P1021 UNH US 5.23
STRYKER CORP Foreign StockUS8636671013 SYK US 5.19
PFIZER INC Foreign StockUS7170811035 PFE US 5.03
BECTON DICKINSON AND CO Foreign StockUS0758871091 BDX US 5.03
MEDTRONIC PLC Foreign StockIE00BTN1Y115 MDT US 5.02
CVS HEALTH CORP Foreign StockUS1266501006 CVS US 4.98
ZOETIS INC Foreign StockUS98978V1035 ZTS US 4.97
BRISTOL-MYERS SQUIBB CO Foreign StockUS1101221083 BMY US 4.93
ABBOTT LABORATORIES Foreign StockUS0028241000 ABT US 4.90
JOHNSON & JOHNSON Foreign StockUS4781601046 JNJ US 4.74
ABBVIE INC Foreign StockUS00287Y1091 ABBV US 4.57
GILEAD SCIENCES INC Foreign StockUS3755581036 GILD US 4.56
MERCK & CO INC Foreign StockUS58933Y1055 MRK US 4.53
ELI LILLY AND CO Foreign StockUS5324571083 LLY US 4.50
AMGEN INC Foreign StockUS0311621009 AMGN US 4.48
ABT US CALL 115 11/20/20 ABBOTT LABORATORIES (21/11/2020) Option 0.00
AMGN US CALL 240 11/20/20 AMGEN INC (21/11/2020) Option 0.00
JNJ US CALL 150 11/20/20 JOHNSON & JOHNSON (21/11/2020) Option 0.00
LLY US CALL 150 11/20/20 ELI LILLY & CO (21/11/2020) Option 0.00
BMY US CALL 62.5 11/20/20 BRISTOL-MYERS SQUIBB CO (21/11/2020) Option 0.00
ABBV US CALL 87.5 11/20/20 ABBVIE INC (21/11/2020) Option 0.00
MDT US CALL 115 11/20/20 MEDTRONIC PLC (21/11/2020) Option 0.00
UNH US CALL 340 11/20/20 UNITEDHEALTH GROUP INC (21/11/2020) Option 0.00
SYK US CALL 230 11/20/20 STRYKER CORP (21/11/2020) Option 0.00
GILD US CALL 62.5 11/20/20 GILEAD SCIENCES INC COM (21/11/2020) Option 0.00
MRK US CALL 80 11/20/20 MERCK & CO INC (21/11/2020) Option 0.00
ZTS US CALL 165 11/20/20 ZOETIS INC (21/11/2020) Option 0.00
PFE US CALL 39 11/20/20 PFIZER INC (21/11/2020) Option 0.00
TMO US CALL 480 11/20/20 THERMO FISHER SCIENTIFIC (21/11/2020) Option 0.00
CVS US CALL 60 11/20/20 CVS CAREMARK CORP (21/11/2020) Option 0.00
BDX US CALL 240 11/20/20 BECTON DICKINSON AND CO (21/11/2020) Option 0.00
DHR US CALL 230 11/20/20 DANAHER CORP (21/11/2020) Option 0.00
HUM US CALL 440 11/20/20 HUMANA INC (21/11/2020) Option 0.00
CI US CALL 180 11/20/20 CIGNA CORPORATION COM (21/11/2020) Option 0.00
ANTM US CALL 300 11/20/20 ANTHEM INC CLL (21/11/2020) Option 0.00
Currency Security 0.00

As at: 23 October 2020
Holdings are subject to change



Distribution details (.csv)

Twelve month trailing distribution yield : 8.26% (as at 23 Oct 2020)

FHITotalCashReinvestedEligible dividendsNon eligible dividendsOther incomeCapital GainsReturn of capitalForeign IncomeForeign tax paid
2020 +$0.73760$0.73760--------
2019 +$0.60210$0.60210-----$0.45593$0.17197$0.02579
2018 +$0.23020$0.23020----$0.10665$0.09384$0.03495$0.00524

(1) Future distribution dates may be amended at any time. (2) Reinvested distributions are not paid in cash but instead remain invested in the Fund. To recognize that these distributions have been allocated to investors for tax purposes the amounts of these distributions should be added to the adjusted cost base of the units held. (3) The characterization of distributions for tax purposes (such as dividends/other income/capital gains etc.) will not be known for certain until after the Fund's tax year end. Therefore investors will be informed of the characterization of the amounts distributed for tax purposes only for the entire year and not with each distribution. For tax purposes these amounts will be reported by brokers on official tax statements.


22 Apr, 2020 - ETF Facts

National Instrument 81-106 Investment Fund Continuous Disclosure requires disclosure of the proxy voting record on an annual basis for the period ending on June 30 of each year. The proxy voting record must be posted on the website no later than August 31 of each year.

Canadian securities law provides that the manager of an investment funds (in this case, CI Investments Inc. ("CI")), acting on behalf of the investment fund, has the right and obligation to vote proxies relating to the investment fund's portfolio securities. As a practical matter, CI delegates this function to the applicable portfolio manager or sub-adviser, as part of the portfolio manager's or sub-adviser's general management of the investment fund assets, subject to oversight by CI. CI generally requires that applicable portfolio managers or sub-advisers vote all proxies in the best interest of CI's funds and their securityholders, as determined solely by the portfolio manager or sub-adviser, and subject to CI's proxy voting policy, the guidelines applicable to the individual portfolio manager or sub-adviser, and applicable legislation. Portfolio managers and sub-advisers are generally expected to vote on any matter for which the investment fund receives proxy materials for a meeting of securityholders of an issuer.

Proxy voting record for the most recent year:

30 Jun, 2020 - Proxy Voting Record

Warning: Documents posted on this website (including, without limitation, prospectuses) are current only as of the date on them

To access the SEDAR filings of CI First Asset Health Care Giants Covered Call ETF (CAD Hedged) please click here